MedPath

The effect of deep relaxation on surgical conditions and morbidity in shoulder surgery

Phase 1
Conditions
Subject undergoing elective or semi-elective surgery to the gleno-humeral joint or the proximal humerus using a deltoideo-pectoral approach.
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
Registration Number
EUCTR2018-002961-21-BE
Lead Sponsor
Z Leuven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
52
Inclusion Criteria

•18 years or older at enrollment
•Subjects who are undergoing elective or semi-elective surgery to the gleno-humeral joint or the proximal humerus using a deltoideo-pectoral approach

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 43
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 9

Exclusion Criteria

•Inability to consent because of mental status
•Open injuries involving the deltoid muscle
•Previous open surgery on the shoulder joint
•American Society of Anesthesiologists (ASA) physical status > II
•Age < 18 or > 75 years old
•Body mass index (BMI) <18,5 or > 35 kg/m²
•Renal insufficiency: glomerular filtration rate < 40 ml/min
• Impaired liver function: hepatic cirrhosis, cholestatic jaundice
• Neuromuscular disease
• Pregnant female subjects
• Breastfeeding female subjects
• Patients receiving medications known to interact with neuromuscular blocking agents
• Allergy to any drug included in the anesthetic protocol

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath